Best PCOS Infertility Treatment Doctors in India

What Women with Polycystic Ovary Syndrome Worry About Most

Polycystic ovary syndrome is the most common cause of irregular ovulation and infertility in women under thirty-five. Patients worry they will never conceive without in vitro fertilisation, that weight loss is being pushed instead of real treatment, and that long-term use of oral medication will harm them. Many have already tried clomiphene citrate without success and feel demoralised. The honest position is that around seventy to eighty percent of women with polycystic ovary syndrome conceive with ovulation induction, intrauterine insemination, or a single in vitro fertilisation cycle when the protocol is matched to ovarian reserve, body mass index, and partner sperm quality.

How Polycystic Ovary Syndrome Infertility Is Diagnosed

Diagnosis follows the Rotterdam criteria: two of three features (irregular ovulation, clinical or biochemical hyperandrogenism, polycystic ovarian morphology on ultrasound). Day two or three blood tests check follicle-stimulating hormone, luteinising hormone, anti-Mullerian hormone, prolactin, thyroid-stimulating hormone, and testosterone. Transvaginal ultrasound counts antral follicles and measures ovarian volume. Glucose tolerance testing and insulin levels screen for insulin resistance. Tubal patency is confirmed with hysterosalpingography. Partner semen analysis is mandatory before any treatment plan is finalised.

Treatment Options for Polycystic Ovary Syndrome Infertility in India

Treatment moves in steps. Lifestyle modification with a five to ten percent weight loss restores ovulation in many cases. Metformin improves insulin sensitivity. Letrozole has overtaken clomiphene citrate as the first-line ovulation induction drug and produces higher live birth rates. Gonadotrophin injections are added when oral drugs fail. Intrauterine insemination follows successful ovulation induction. In vitro fertilisation with a gonadotrophin-releasing hormone antagonist protocol and an agonist trigger reduces the risk of ovarian hyperstimulation syndrome, which polycystic ovaries are prone to. Laparoscopic ovarian drilling remains an option for selected women. Fortis La Femme, Medanta, Apollo Fertility, Manipal Fertility, and Cloudnine run dedicated polycystic ovary syndrome clinics with combined endocrinology and reproductive medicine teams.

Success Rates and Follow-Up After Polycystic Ovary Syndrome Treatment

Letrozole produces ovulation in about seventy-five percent of women and live birth rates of around twenty to twenty-five percent per cycle in those under thirty-five. Intrauterine insemination after ovulation induction achieves pregnancy in fifteen to twenty percent per cycle. In vitro fertilisation cycles in good-responder polycystic ovary syndrome patients deliver clinical pregnancy rates of forty-five to fifty-five percent per fresh embryo transfer and higher with frozen blastocyst transfer. Follow-up after delivery includes screening for type two diabetes, which polycystic ovary syndrome carries a lifelong risk of.

How to Choose the Right Fertility Specialist for Polycystic Ovary Syndrome

Ask how many polycystic ovary syndrome cycles the centre runs each year, what proportion use letrozole rather than clomiphene citrate, what the ovarian hyperstimulation syndrome rate is, and whether elective freeze-all and frozen embryo transfer is offered to reduce risk. Confirm that ovulation induction is monitored with serial ultrasound rather than blind cycles. Ask about cumulative live birth rates per egg retrieval, not just per transfer. Centres that publish annual outcome reports and follow European Society of Human Reproduction and Embryology guidelines are usually the right choice.

Support for International Patients

Polycystic ovary syndrome care in India costs a fraction of treatment in the United Kingdom, the United States, or the United Arab Emirates without compromising on protocols or laboratory standards. Cancer Rounds arranges medical visa invitation letters, accommodation near the fertility centre, multilingual support in eleven plus languages, and pharmacy delivery of gonadotrophin injections. We have helped women from Nigeria, Kenya, Bangladesh, Iraq, Ethiopia, and Oman complete ovulation induction, intrauterine insemination, and in vitro fertilisation cycles in India with documented home transfer of records.

Frequently Asked Questions

Do I have to lose weight before starting treatment?

A five to ten percent weight loss markedly improves ovulation, ovarian response, and pregnancy rates, but treatment is not refused on weight alone. Younger women with normal weight can start immediately.

Is letrozole safe for the baby?

Yes. Multiple large studies including the National Institute of Child Health and Human Development PPCOS-II trial show no increase in birth defects compared to clomiphene citrate or natural conception.

What is ovarian hyperstimulation syndrome and how is it prevented?

Ovarian hyperstimulation syndrome is exaggerated response to fertility drugs causing abdominal swelling, vomiting, and fluid shifts. Antagonist protocols, agonist triggers, dose adjustment, and freeze-all cycles bring the severe rate below one percent.

How many cycles before moving to in vitro fertilisation?

Most centres offer three to six cycles of letrozole with or without intrauterine insemination before recommending in vitro fertilisation, unless other factors (age over thirty-five, tubal block, low ovarian reserve) call for earlier escalation.

Will polycystic ovary syndrome come back after pregnancy?

Polycystic ovary syndrome is a lifelong condition. Periods often remain irregular after delivery, and long-term risks for type two diabetes and endometrial protection need continued follow-up.

Can I take care of polycystic ovary syndrome without hormones?

Diet, exercise, and metformin form the non-hormonal foundation. Letrozole is not a contraceptive hormone but an aromatase inhibitor used briefly. True hormonal treatment is mainly for women not currently trying to conceive.